Vaxneuvance 0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1QAR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,091
Award facts
- Contract value 100% obligated
- $12,090.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,090.71 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 14, 2026. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen). The company maintains a significant federal procurement presence, consistently delivering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's Medical Supply Chain relies on AmerisourceBergen's extensive portfolio and logistical capabilities to meet critical pharmaceutical and vaccine needs for military personnel and related federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F1QAR?
SPE2DR26F1QAR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1QAR worth?
The government has obligated $12,091 on SPE2DR26F1QAR.
Is contract SPE2DR26F1QAR an order under another contract?
Yes. SPE2DR26F1QAR is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1QAR competed?
The extent of competition for SPE2DR26F1QAR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award